Metabolic Disorders

Metabolic Disorders

UAB researchers have developed a unique class of compounds that are effective in preventing and/or treating metabolic diseases.

Novel small molecule compounds, are promising treatments for type II diabetes and other metabolic disorders, as well as prevention of estrogen receptor negative breast cancers

Metabolic Disorders

The newly identified TXNIP–miR-204–MAFA–insulin pathway may contribute to diabetes progression and provides new insight into TXNIP function and microRNA biology in health and disease.

Therapeutic – treatment of diabetes